Table 1.

Patient Characteristics by Discharge NOAC and Warfarin Use

Variable	Total Population (n=61655)	Discharged on NOAC (n=6835)	Discharged on Warfarin (n=54820)	p-value
Female sex	53.1	51.8	53.3	0.016
Age	79 (70–85)	77 (69–84)	79 (70–85)	<0.001
≥75	64.4	59.2	65.1	<0.001
Race/ethnicity				0.001
White	81.0	82.7	80.8
Black	8.7	7.3	8.9
Hispanic	4.8	4.8	4.8
Asian	2.0	1.9	2.0
Medical history
Heart failure	16.8	12.8	17.3	<0.001
Hypertension	79.9	79.3	79.9	0.211
Diabetes mellitus	29.6	26.7	30.0	<0.001
Prior stroke/TIA	34.7	33.6	34.9	0.041
Prior atrial fibrillation/flutter	77.0	77.1	77.0	0.911
Coronary artery disease	34.3	30.9	34.8	<0.001
Peripheral vascular disease	5.7	4.9	5.9	0.001
Carotid stenosis	4.2	4.0	4.2	0.400
Dyslipidemia	48.5	48.6	48.5	0.957
Prosthetic heart valve	3.9	1.4	4.2	<0.001
Smoker	8.2	8.0	8.2	0.528
Admission medications
Antiplatelet therapy	40.4	45.4	39.8	<0.001
Anticoagulation	45.1	33.1	46.6	<0.001
Admission exam/labs:
Systolic BP (mmHg)	150(133–170)	151(134–172)	150(133–169)	<0.001
Diastolic BP (mmHg)	80 (69–92)	80 (70–92)	80 (69–92)	<0.001
Heart rate	78 (68–92)	77 (67–91)	78 (68–92)	0.001
Body mass index	27.0 (23.6–31.2)	27.0 (23.8–31.2)	27.0 (23.6–31.2)	0.460
Hemoglobin A1c	6.9 (6.2–7.9)	6.9 (6.2–7.9)	6.9 (6.2–7.9)	0.799
Creatinine (mg/dL)	1.0 (0.8–1.3)	1.0 (0.8–1.2)	1.0 (0.8–1.3)	<0.001
GFR ≥30 mg/dL/1.73m2	73.1	75.2	72.9	<0.001
Total cholesterol	151(126–179)	152(128–181)	150(126–179)	0.002
Median NIH stroke scale	5 (2–11)	3 (1–8)	5 (2–11)	<0.001
NIH stroke scale ≥11	18.3	14.0	18.8	<0.001
Insurance status				<0.001
Medicare	42.0	39.0	42.3
Medicaid	6.2	5.4	6.3
Insured/HMO	38.0	41.7	37.6
Self-pay	2.1	1.4	2.2

Values represent percentages or medians (interquartile range).

BP indicates blood pressure; GFR, glomerular filtration rate; HMO, health maintenance organization; NIH, National Institute of Health (higher scores on NIH stroke scale indicate greater stroke severity); NOAC, novel oral anticoagulant